연구성과로 돌아가기
JCR 2022 저널 목록 (1516 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DOWN BEAT | MAHER PUBL INC | 0012-5768 | 0012-5768 | AHCI | MUSIC | 14 | <0.1 | N/A | 100.0 | N/A | N/A | <0.1 | N/A | <0.1 | 0.2 | 0.00 | 106/115 | Q4 | 8.26 | 0.000 | 0.012 | 0.025 | Q4 | 11 | 100.0% | N/A | 999.9 | 11 | 0.0% | 2025-04-21 10:18:05 | 바로가기 |
| Downside Review | SAGE PUBLICATIONS LTD | 0012-5806 | 2397-3498 | ESCI | RELIGION | 36 | <0.1 | N/A | 100.0 | N/A | N/A | 0.1 | N/A | <0.1 | <0.1 | 0.13 | 296/341 | Q4 | 13.34 | 0.000 | 0.012 | 0.110 | Q3 | 8 | 100.0% | N/A | 71.6 | 8 | 26.7% | 2025-04-21 10:34:33 | 바로가기 |
| Doxa Comunicacion | UNIV SAN PABLO, FAC HUMANIDADES & CIENCIAS COMUNICACION | 1696-019X | 2386-3978 | ESCI | COMMUNICATION | 141 | 0.6 | N/A | 100.0 | N/A | N/A | 0.7 | N/A | 0.5 | 0.1 | 0.15 | 186/219 | Q4 | 15.30 | 0.000 | 0.046 | 0.161 | Q3 | 35 | 97.1% | 3.7 | 7.9 | 34 | 82.9% | 2025-04-21 09:40:10 | 바로가기 |
| Doxa-Cuadernos de Filosofia y Derecho | UNIV ALICANTE | 0214-8676 | 2386-4702 | ESCI | PHILOSOPHY | 117 | 0.2 | N/A | 100.0 | N/A | N/A | 0.1 | N/A | 0.1 | <0.1 | 0.17 | 230/328 | Q3 | 30.03 | 0.000 | 0.032 | 0.131 | Q2 | 23 | 95.6% | 19.9 | 17.0 | 22 | 100.0% | 2025-04-21 10:25:10 | 바로가기 |
| Drama Therapy Review | INTELLECT LTD | 2054-7668 | 2054-7676 | ESCI | THEATER | 123 | 1.1 | N/A | 100.0 | N/A | N/A | 0.9 | N/A | 0.8 | 0.6 | 4.00 | 1/51 | Q1 | 99.02 | 0.000 | 0.024 | 0.129 | Q2 | 13 | 84.6% | 3.0 | 6.0 | 11 | 0.0% | 2025-04-21 10:39:11 | 바로가기 |
| Dress-The Journal of the Costume Society of America | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | 0361-2112 | 2042-1729 | AHCI | HUMANITIES, MULTIDISCIPLINARY | 47 | 0.4 | N/A | 100.0 | N/A | N/A | 0.6 | N/A | 0.4 | <0.1 | 0.99 | 84/409 | Q1 | 79.58 | 0.000 | 0.031 | 0.350 | Q2 | 11 | 100.0% | N/A | 53.5 | 11 | 5.6% | 2025-04-21 10:03:38 | 바로가기 |
| Drevnyaya Rus-Voprosy Medievistiki | INDRIK | 2071-9574 | 2071-9574 | ESCI | MEDIEVAL & RENAISSANCE STUDIES | 87 | 0.2 | N/A | 100.0 | N/A | N/A | 0.2 | N/A | 0.1 | 0.1 | 1.11 | 25/82 | Q2 | 70.12 | 0.001 | 0.125 | 0.242 | Q2 | 58 | 100.0% | N/A | 19.1 | 58 | 0.0% | 2025-04-21 10:16:35 | 바로가기 |
| Droit et Cultures | EDITIONS L HARMATTAN | 0247-9788 | 0247-9788 | ESCI | LAW | 42 | 0.2 | N/A | 100.0 | N/A | N/A | 0.2 | N/A | 0.2 | N/A | 0.14 | 347/425 | Q4 | 18.47 | 0.000 | 0.014 | 0.072 | Q3 | 0 | N/A | N/A | N/A | 0 | 27.5% | 2025-04-21 10:07:20 | 바로가기 |
| Drone Systems and Applications | CANADIAN SCIENCE PUBLISHING | N/A | 2564-4939 | ESCI | REMOTE SENSING | 17 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | 0.5 | 0.24 | 46/59 | Q4 | 22.88 | 0.000 | 0.002 | N/A | N/A | 23 | 91.3% | N/A | 5.9 | 21 | 96.2% | 2025-04-21 10:34:47 | 바로가기 |
| Drug Discoveries and Therapeutics | INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT | 1881-7831 | 1881-784X | ESCI | PHARMACOLOGY & PHARMACY | 1,200 | 3.1 | N/A | 100.0 | N/A | N/A | 2.1 | N/A | 3.0 | 0.3 | 1.03 | 80/366 | Q1 | 78.28 | 0.001 | 0.249 | 0.446 | Q2 | 37 | 83.8% | 5.6 | 7.7 | 31 | 100.0% | 2025-04-21 10:23:54 | 바로가기 |
| Drug Healthcare and Patient Safety | DOVE MEDICAL PRESS LTD | 1179-1365 | 1179-1365 | ESCI | HEALTH CARE SCIENCES & SERVICES | 398 | 1.6 | N/A | 100.0 | N/A | N/A | 1.9 | N/A | 1.6 | 0.2 | 0.44 | 124/168 | Q3 | 26.49 | 0.000 | 0.073 | 0.414 | Q2 | 19 | 79.0% | 6.9 | 8.2 | 15 | 98.6% | 2025-04-21 10:00:17 | 바로가기 |
| Drug Research | GEORG THIEME VERLAG KG | 2194-9379 | 2194-9387 | ESCI | PHARMACOLOGY & PHARMACY | 1,492 | 2.2 | N/A | 100.0 | N/A | N/A | 2.2 | N/A | 2.2 | 0.3 | 0.40 | 274/366 | Q3 | 25.27 | 0.001 | 0.237 | 0.296 | Q2 | 64 | 78.1% | 5.0 | 8.4 | 50 | 1.4% | 2025-04-21 10:23:53 | 바로가기 |
| Drug Target Insights | ABOUTSCIENCE SRL | 1177-3928 | 1177-3928 | ESCI | PHARMACOLOGY & PHARMACY | 238 | 2.7 | N/A | 100.0 | N/A | N/A | 3.6 | N/A | 2.7 | 0.1 | 0.49 | 247/366 | Q3 | 32.65 | 0.000 | 0.024 | 0.658 | Q1 | 11 | 81.8% | 9.2 | 6.6 | 9 | 100.0% | 2025-04-21 10:24:01 | 바로가기 |
| DRUGS & THERAPY PERSPECTIVES | SPRINGERNATURE | 1172-0360 | 1179-1977 | ESCI | PHARMACOLOGY & PHARMACY | 309 | 1.2 | N/A | 100.0 | N/A | N/A | N/A | N/A | 1.1 | 0.3 | 0.18 | 328/366 | Q4 | 10.52 | 0.000 | 0.100 | N/A | N/A | 75 | 92.0% | 2.7 | 3.9 | 69 | 9.5% | 2025-04-21 10:24:00 | 바로가기 |
| Drugs and Alcohol Today | EMERALD GROUP PUBLISHING LTD | 1745-9265 | 2042-8359 | ESCI | SUBSTANCE ABUSE | 219 | 0.9 | N/A | 100.0 | N/A | N/A | 0.9 | N/A | 0.9 | N/A | 0.30 | 45/54 | Q4 | 17.59 | 0.000 | 0.084 | 0.297 | Q2 | 0 | N/A | 4.0 | N/A | 0 | 18.3% | 2025-04-21 10:38:01 | 바로가기 |
페이지 이동: